[Correspondence] Semaglutide treatment fails but might prevent Alzheimer's disease | ClinicLens
We read with interest Lon S Schneider's Comment1 on the evoke and evoke+ trials2 of oral semaglutide in early symptomatic Alzheimer's disease. While we agree that these studies do not support semaglutide as a treatment for established Alzheimer's disease, we cautio
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.